ÖZET
Akut böbrek hasarı (ABH), perioperatif dönemin önemli komplikasyonlarından birisidir. Perioperatif ABH kronik böbrek hastalığı riskini, diyaliz gereksinimini, periopeartif maliyeti ve mortalite şansını artırır. Hastalarımızın ameliyat öncesi riskleri ve cerrahi prosedürlerin ağırlığına bağlı risk faktörleri ABH oluşumuna katkıda bulunur. ABH’yi çok erken teşhis edebilecek yeni biyobelirteçlere ihtiyaç duyulmaktadır. Yeni biyobelirteçlerin potansiyel rolleri ve bunların tanıya ve prognostik değerlendirmeye katkıları detaylı araştırmalar gerektirmektedir. Böbrek Hastalığı: Küresel Sonuçların İyileştirilmesi tarafından sağlanan ABH’yi önlemeye yönelik öneriler klinisyenler için yararlı ve pratik bir rehber oluşturmaktadır. Perioperatif hemodinami ve oksijenasyonun ABH’yi önlemeye katkıda bulunduğu görülmektedir. Genel olarak, nefrotoksik ajanlara maruz kalmanın azaltılması, tedavinin etkisini daha da azaltmak için tavsiye edilir. Bu derlemede perioperatif dönemde ABH’ye yol açan risk faktörlerini özetlemeyi amaçladık. Ayrıca, erken tanının avantajlarını, ABH’nin önlenmesine katkısı olacak girişimleri ve erken yönetimini özetlemeye gayret ettik.
References
1
Nepogodiev D, Martin J, Biccard B, Makupe A, Bhangu A; National Institute for Health Research Global Health Research Unit on Global Surgery. Global burden of postoperative death. Lancet 2019;393:401.
2
Mathis MR, Naik BI, Freundlich RE, Shanks AM, Heung M, Kim M, et al. Preoperative Risk and the Association between Hypotension and Postoperative Acute Kidney Injury. Anesthesiology 2020;132:461-75.
3
Ahuja S, Mascha EJ, Yang D, Maheshwari K, Cohen B, Khanna AK, et al. Associations of Intraoperative Radial Arterial Systolic, Diastolic, Mean, and Pulse Pressures with Myocardial and Acute Kidney Injury after Noncardiac Surgery: A Retrospective Cohort Analysis. Anesthesiology 2020;132:291-306.
4
Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005;16:162-8.
5
Woo SH, Zavodnick J, Ackermann L, Maarouf OH, Zhang J, Cowan SW. Development and Validation of a Web-Based Prediction Model for AKI after Surgery. Kidney360 2021;2:215-23.
6
Park S, Cho H, Park S, Lee S, Kim K, Yoon HJ, et al. Simple Postoperative AKI Risk (SPARK) Classification before Noncardiac Surgery: A Prediction Index Development Study with External Validation. J Am Soc Nephrol 2019;30:170-81.
7
Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, et al. Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis. Anesthesiology 2017;126:47-65.
8
Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 2015;123:515-23.
9
Sessler DI, Meyhoff CS, Zimmerman NM, Mao G, Leslie K, Vásquez SM, et al. Period-dependent Associations between Hypotension during and for Four Days after Noncardiac Surgery and a Composite of Myocardial Infarction and Death: A Substudy of the POISE-2 Trial. Anesthesiology 2018;128:317-27.
10
Monk TG, Bronsert MR, Henderson WG, Mangione MP, Sum-Ping ST, Bentt DR, et al. Association between Intraoperative Hypotension and Hypertension and 30-day Postoperative Mortality in Noncardiac Surgery. Anesthesiology 2015;123:307-19.
11
Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth 2018;121:706-21.
12
Turan A, Chang C, Cohen B, Saasouh W, Essber H, Yang D, et al. Incidence, Severity, and Detection of Blood Pressure Perturbations after Abdominal Surgery: A Prospective Blinded Observational Study. Anesthesiology 2019;130:550-9.
13
Saugel B, Sessler DI. Perioperative Blood Pressure Management. Anesthesiology 2021;134:250-61.
14
Reich DL, Hossain S, Krol M, Baez B, Patel P, Bernstein A, et al. Predictors of hypotension after induction of general anesthesia. Anesth Analg 2005;101:622-8.
15
Cheung CC, Martyn A, Campbell N, Frost S, Gilbert K, Michota F, et al. Predictors of intraoperative hypotension and bradycardia. Am J Med 2015;128:532-8.
16
Shaw AD, Khanna AK, Smischney NJ, Shenoy AV, Boero IJ, Bershad M, et al. Intraoperative hypotension is associated with persistent acute kidney disease after noncardiac surgery: a multicentre cohort study. Br J Anaesth 2022;129:13-21.
17
von Groote TC, Ostermann M, Forni LG, Meersch-Dini M, Zarbock A; PrevAKI Investigators. The AKI care bundle: all bundle components are created equal-are they? Intensive Care Med 2022;48:242-5.
18
Turan A, Cohen B, Rivas E, Liu L, Pu X, Maheshwari K, et al. Association between postoperative haemoglobin and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Br J Anaesth 2021;126:94-101.
19
Xu K, Rosenstiel P, Paragas N, Hinze C, Gao X, Huai Shen T, et al. Unique Transcriptional Programs Identify Subtypes of AKI. J Am Soc Nephrol 2017;28:1729-40.
20
Jung M, Brüne B, Hotter G, Sola A. Macrophage-derived Lipocalin-2 contributes to ischemic resistance mechanisms by protecting from renal injury. Sci Rep 2016;6:21950.
21
Lee SA, Noel S, Kurzhagen JT, Sadasivam M, Pierorazio PM, Arend LJ, et al. CD4(+) T Cell-Derived NGAL Modifies the Outcome of Ischemic Acute Kidney Injury. J Immunol 2020;204:586-95.
22
Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004;15:3073-82.
23
Koyner JL, Shaw AD, Chawla LS, Hoste EA, Bihorac A, Kashani K, et al. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI. J Am Soc Nephrol 2015;26:1747-54.
24
Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;17:25.
25
Lameire N, Vanmassenhove J, Van Biesen W, Vanholder R. The cell cycle biomarkers: promising research, but do not oversell them. Clin Kidney J 2016;9:353-8.
26
Daubin D, Cristol JP, Dupuy AM, Kuster N, Besnard N, Platon L, et al. Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients. PLoS One 2017;12:e0169674
27
Neuhofer W, Beck FX. Response of renal medullary cells to osmotic stress. Contrib Nephrol 2005;148:21-34.
28
Belcher JM, Sanyal AJ, Peixoto AJ, Perazella MA, Lim J, Thiessen-Philbrook H, et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology 2014;60:622-32.
29
Paragas N, Qiu A, Zhang Q, Samstein B, Deng SX, Schmidt-Ott KM, et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 2011;17:216-22.
30
Nephrology ISo: KDIGO Clinical Practice Guideline for Acute Kidney Injury. Available at: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf. Accessed 08/22/2022
31
Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 2017;43:1749.
32
Bullivant EM, Wilcox CS, Welch WJ. Intrarenal vasoconstriction during hyperchloremia: role of thromboxane. Am J Physiol 1989;256:152-7.
33
McCluskey SA, Karkouti K, Wijeysundera D, Minkovich L, Tait G, Beattie WS. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg 2013;117:412-21.
34
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
35
Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O’Brien PC, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007;146:233-43.
36
Bhamidipati CM, LaPar DJ, Stukenborg GJ, Morrison CC, Kern JA, Kron IL, et al. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2011;141:543-51.
